| Residential College | false |
| Status | 已發表Published |
| Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside | |
Bao, Xuhui ; Yongjun Liang; Hanman Chang; CAI TIANJI ; Baijie Feng; Konstantin Gordon; Yuekun Zhu; Hailian Shi; Yundong He; Liyi Xie
| |
| 2024-01 | |
| Source Publication | Signal Transduction and Targeted Therapy
 |
| Volume | 9Issue:13 |
| DOI | https://doi.org/10.1038/s41392-023-01690-3 |
| Fulltext Access | |
| Citation statistics | |
| Document Type | Journal article |
| Collection | DEPARTMENT OF SOCIOLOGY |
| Corresponding Author | Bao, Xuhui; Yundong He; Liyi Xie |
| Recommended Citation GB/T 7714 | Bao, Xuhui,Yongjun Liang,Hanman Chang,et al. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside[J]. Signal Transduction and Targeted Therapy, 2024, 9(13). |
| APA | Bao, Xuhui., Yongjun Liang., Hanman Chang., CAI TIANJI., Baijie Feng., Konstantin Gordon., Yuekun Zhu., Hailian Shi., Yundong He., & Liyi Xie (2024). Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside. Signal Transduction and Targeted Therapy, 9(13). |
| MLA | Bao, Xuhui,et al."Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside".Signal Transduction and Targeted Therapy 9.13(2024). |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment